Erythropoietin/erythropoietin-receptor system is involved in angiogenesis in human hepatocellular carcinoma.
about
Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q.Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes.Prognostic significance of erythropoietin in pancreatic adenocarcinomaAssociation between pharmaceutical support and basic science research on erythropoiesis-stimulating agentsErythropoietin, a novel versatile player regulating energy metabolism beyond the erythroid systemRecombinant human erythropoietin promotes the acquisition of a malignant phenotype in head and neck squamous cell carcinoma cell lines in vitroCentrality-based pathway enrichment: a systematic approach for finding significant pathways dominated by key genesErythropoietin and cancer: the unintended consequences of anemia correctionPrognostic significance of erythropoietin and erythropoietin receptor in gastric adenocarcinomaErythropoietin and erythropoietin receptor in hepatocellular carcinoma: correlation with vasculogenic mimicry and poor prognosis.Characterization of the erythropoietin/erythropoietin receptor axis in a rat model of liver damage and cholangiocarcinoma developmentRole of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients.Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts.Expression and functional significance of the erythropoietin receptor in hepatocellular carcinoma.Darbepoetin inhibits proliferation of hepatic cancer cells in the presence of TGF-β.Erythropoietin and Its Angiogenic Activity.Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma.Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease.Erythropoietin promoted the proliferation of hepatocellular carcinoma through hypoxia induced translocation of its specific receptor.
P2860
Q30488297-9F2D14BF-77BE-414E-A937-99F28E801DCCQ33985838-46E990DE-3127-4EBD-BF05-211141CFC803Q33988762-CDA0189F-6B7C-47C9-91C6-6BF6491436A3Q34068226-6E063817-AB8B-49CF-AECB-361E0574E9ECQ34100489-8F35113F-BD58-48F0-904F-AE3F95F904D7Q34107767-951DFFB7-A92E-44C0-8608-EC3D58990708Q34294628-81276F35-9EC2-4BAB-BD17-9F52DAF85426Q34488415-409B04D4-53F7-4E60-B2C2-9AF285363711Q35404296-09471DE1-C5F2-48CC-9AC2-3897B1AC9B7FQ35741127-04E65D7B-68BA-435D-B047-C51C8AC9B854Q36611934-15049158-AE84-47B7-A84C-9ADA9F4BEF76Q37046655-55094760-EAD4-407C-B24D-2E8EC9F6DB87Q37253676-34204974-8D3A-4BF1-8AE7-D60F11FAC52BQ37350312-5A0A36B7-66D3-44FD-A7AE-8536EEE4253CQ39121853-387FDB2A-8D24-4F90-8559-58DD4938B6D6Q39432541-7AD5EE79-098E-4282-ADAA-6439255662F5Q42202989-998B4189-5475-4317-98D4-86F5F20E81E5Q44034165-E6336CEF-9D6B-483D-82CD-3C57F3D417C3Q44963037-2621881A-2B71-4361-814C-8FE59FDC8F6DQ47143849-A8970F72-67B9-47B0-AF3D-E75F81445D59
P2860
Erythropoietin/erythropoietin-receptor system is involved in angiogenesis in human hepatocellular carcinoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Erythropoietin/erythropoietin- ...... uman hepatocellular carcinoma.
@ast
Erythropoietin/erythropoietin- ...... uman hepatocellular carcinoma.
@en
type
label
Erythropoietin/erythropoietin- ...... uman hepatocellular carcinoma.
@ast
Erythropoietin/erythropoietin- ...... uman hepatocellular carcinoma.
@en
prefLabel
Erythropoietin/erythropoietin- ...... uman hepatocellular carcinoma.
@ast
Erythropoietin/erythropoietin- ...... uman hepatocellular carcinoma.
@en
P2093
P2860
P1433
P1476
Erythropoietin/erythropoietin- ...... human hepatocellular carcinoma
@en
P2093
P2860
P304
P356
10.1111/J.1365-2559.2007.02654.X
P577
2007-04-01T00:00:00Z